KORE Appointed to Board of Directors for The Medical Alert Monitoring[...]
Theriva™ Biologics hablará sobre el diseño del ensayo VIRAGE, un[...]
Theriva™ Biologics to Discuss the Trial Design for VIRAGE – a Phase 2b[...]
08/09/2022 | Press release | Distributed by Public on 08/09/2022 14:21
Please select the service you want to use:
Smartlinks | The RealReal Inc. | News | Technology | Internet | Internet and Online Services | E-Commerce | Local News | Finance | Security Markets | Security Markets | Company News | Top Company News | Financial Services | Investment Services | Retail | E-Commerce | Public Companies | E-Commerce Companies | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact